5/3/2013

Foundation Medicine has entered a collaboration with Memorial Sloan-Kettering Cancer Center for the development of a test to help identify the best hematologic cancer treatments for individual patients. The test will employ RNA and DNA sequencing to classify hematologic conditions.

Related Summaries